A phase II study of abemaciclib in patients with brain metastases secondary to hormone receptor–positive breast cancer

SM Tolaney, S Sahebjam, E Le Rhun, T Bachelot… - Clinical Cancer …, 2020 - AACR
Purpose: The primary objective was to evaluate intracranial objective response rate (iORR)
in patients receiving abemaciclib with brain or leptomeningeal metastases (LM) secondary …

The monoterpenoid perillyl alcohol: Anticancer agent and medium to overcome biological barriers

TC Chen, CO da Fonseca, D Levin, AH Schönthal - Pharmaceutics, 2021 - mdpi.com
Perillyl alcohol (POH) is a naturally occurring monoterpenoid related to limonene that is
present in the essential oils of various plants. It has diverse applications and can be found in …

Behind Brain Metastases Formation: Cellular and Molecular Alterations and Blood–Brain Barrier Disruption

J Godinho-Pereira, AR Garcia, I Figueira… - International journal of …, 2021 - mdpi.com
Breast cancer (BC) brain metastases is a life-threatening condition to which accounts the
poor understanding of BC cells'(BCCs) extravasation into the brain, precluding the …

Enhanced brain delivery and therapeutic activity of trastuzumab after blood-brain barrier opening by NEO100 in mouse models of brain-metastatic breast cancer

W Wang, H He, NI Marín-Ramos, S Zeng… - Neuro …, 2021 - academic.oup.com
Background The antitumor efficacy of human epidermal growth factor receptor 2 (HER2)-
targeted therapies, such as humanized monoclonal antibody trastuzumab (Herceptin® …

Heterogeneity and vascular permeability of breast cancer brain metastases

MV Babak, MR Zalutsky, IV Balyasnikova - Cancer letters, 2020 - Elsevier
Improvements in the diagnosis and treatment of systemic breast cancer have led to a
prolongation in patient survival. Unfortunately, these advances are also associated with an …

Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis

S Xiong, X Tan, X Wu, A Wan, G Zhang… - Therapeutic …, 2023 - journals.sagepub.com
Breast cancer (BC) is the most commonly diagnosed cancer worldwide. Advanced BC with
brain metastasis (BM) is a major cause of mortality with no specific or effective treatment …

Enhanced brain entry of checkpoint-inhibitory therapeutic antibodies facilitated by intraarterial NEO100 in mouse models of brain-localized malignancies

W Wang, H He, S Zeng, HY Cho, RO Minea… - Journal of …, 2023 - thejns.org
OBJECTIVE Immune checkpoint-inhibitory therapeutic antibodies have shown striking
activity against several types of cancers but are less effective against brain-localized …

Actein Inhibits tumor growth and metastasis in HER2-positive breast tumor bearing mice via suppressing AKT/MTOR and RAS/RAF/MAPK signaling pathways

XX Wu, GGL Yue, JR Dong, CWK Lam… - Frontiers in …, 2020 - frontiersin.org
HER2-positive breast cancer accounts for 15–20% in breast cancer and 50% of the
metastatic HER2-positive breast cancer patients died of central nervous system progression …

[HTML][HTML] Endocrine resistant breast cancer: brain metastasis

M Willman, J Willman, B Lucke-Wold - Exploration of targeted anti …, 2022 - ncbi.nlm.nih.gov
Endocrine resistant breast cancer metastasis continues to serve as a significant clinical
challenge with high morbidity and mortality for patients. As the number of breast cancer …

[HTML][HTML] Identification of markers associated with brain metastasis from breast cancer through bioinformatics analysis and verification in clinical samples

Y Gao, J Liu, X Qian, X He - Gland Surgery, 2021 - ncbi.nlm.nih.gov
Background Brain metastasis from breast cancer (BC) is an important cause of BC-related
death. The present study aimed to identify markers of brain metastasis from BC. Methods …